Today: 19 July 2026
Linde stock edges higher as tech retreat drags Wall Street in thin year-end trade
29 December 2025
1 min read

Linde stock edges higher as tech retreat drags Wall Street in thin year-end trade

NEW YORK, December 29, 2025, 13:26 ET — Regular session

  • Linde shares rose about 0.3% as broader U.S. equities slipped.
  • Year-end trading volumes stayed light ahead of the New Year’s holiday market closure.
  • Investors are watching Fed minutes, jobless claims and Linde’s next earnings update.

Linde shares rose 0.3% to $426.07 in early afternoon trading on Monday, after moving between $423.65 and $427.29 in the session.

The industrial gases maker held up even as U.S. stocks dipped from record highs in thin, holiday-shortened trading — a setup that can exaggerate moves in individual names.

“It’s a very light trading week ahead; volume is low,” said Sam Stovall, chief investment strategist at CFRA Research in New York. He pointed to tax-loss harvesting — selling losing positions to offset capital-gains taxes — as one factor that can distort late-year flows. Reuters

The SPDR S&P 500 ETF Trust was down about 0.5%, with heavyweight technology and AI-linked shares leading the broader pullback, Reuters reported. Investors are also looking to minutes from the Federal Reserve’s prior meeting and weekly jobless claims later this week, with U.S. markets shut on Thursday for New Year’s Day.

Linde, the world’s largest industrial gases company, supplies oxygen, nitrogen and hydrogen to customers ranging from factories to hospitals, leaving the stock sensitive to shifts in industrial demand but often steadied by long-term supply contracts.

Peer Air Products & Chemicals edged higher as well, while the broader market stayed in the red.

The company’s investor website lists its most recent corporate update as its third-quarter results released on Oct. 31, leaving few fresh company-specific catalysts for the stock in Monday’s trade.

In that quarterly update, Linde forecast fourth-quarter adjusted earnings per share — a profit measure that strips out some one-off items — of $4.10 to $4.20, citing weaker volumes in Europe. It reaffirmed a full-year outlook for 5% to 6% growth in adjusted EPS, Reuters reported.

Investors are now focused on whether European volumes stabilize and how pricing and new project wins feed into 2026 guidance when Linde reports next.

Nasdaq’s earnings calendar estimates Linde will report again on Feb. 5.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Fifth Third tops Q2 2026 forecasts on strong Comerica synergy performance
    July 19, 2026, 7:43 AM EDT. Fifth Third Bancorp posted Q2 2026 revenue of $3.28 billion, rising 46% YoY and exceeding estimates by 1%, as it completed its first full quarter since merging with Comerica. Adjusted EPS came in at $1.02, beating analyst forecasts by 4%. The lender increased its full-year net interest income outlook to $8.74-$8.80 billion while reducing expense guidance to $7.22-$7.26 billion, and projected over 40% adjusted pre-provision net revenue growth from 2025. Net charge-offs dropped to 30 basis points, the lowest since mid-2023. Consumer deposits at Comerica's Southwest branches climbed to $2.5 billion, more than twice the $1 billion goal, propelling loan gains. The surge in deposits led to a 2% quarter-on-quarter increase in commercial loans, with commercial client retention from Comerica at 99.4%. Fifth Third aims to deliver $850 million in merger synergies by Q4 after the Labor Day systems transition.
Micron slips premarket: dividend day and Fed minutes put MU back in focus
Previous Story

Micron slips premarket: dividend day and Fed minutes put MU back in focus

Eli Lilly stock today: LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugs
Next Story

Eli Lilly stock today: LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugs

Go toTop